Osteoporosis

Similar items

• Community Pharmacist-Provided Osteoporosis Screening and Education: Impact on Patient Knowledge

  Scholarly record2016Andrea L. Brookhart, K. Michelle Brown Fountain, Leticia R. Moczygemba, Jean-Venable R. Goode

  Objective: To evaluate the impact pharmacist-provided screening and education had on patient knowledge of osteoporosis and preventive strategies. Methods: A prospective, randomized, controlled study was conducted at 16 locations of a national supermarket chain pharmacy in the Ric

• Molecular Therapies for Disuse Osteoporosis

  Scholarly record2007Ted A. Bateman

  Microgravity causes changes in physiological systems that are both detrimental to human health and valuable for biomedical research. Some of the most pronounced and long-term changes occur in skeletal tissue, which experiences a profound and rapid wasting. Finding a countermeasur

• Reasons for not initiating osteoporosis therapy among a managed care population

  Scholarly record2015Patient preference and adherenceJingbo Yu, Susan K Brenneman, Vasilisa Sazonov, Ankita Modi

  BACKGROUND Many women with osteoporosis do not initiate osteoporosis treatment. OBJECTIVE To examine patients' reasons for not initiating osteoporosis treatment among women with osteoporosis. METHODS Survey recipients were identified from a national US claims database and include

• Assessment of Osteoporosis in Family Medicine Obtained by Ultrasound Densitometry

  Scholarly record2013Acta informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : casopis Drustva za medicinsku informatiku BiHEsad Alibasic, Enisa Ramic, Olivera Batic Mujanovic, Enes Avdibasic

  INTRODUCTION Osteoporosis is a disease characterized by a decrease in bone mineral density, making bones become less rigid, and therefore susceptible to fractures, either spontaneously or with force, which is lower than otherwise needed for healthy bones fractured. Nearly 10% of

• New Issues in the Management of Osteoporosis

  Scholarly record2011Journal of osteoporosisJoonas Sirola, Manuel Diaz Curiel, Risto Honkanen, Jun Iwamoto

  Osteoporosis results in significant morbidity and medical costs while effective treatment options are also evolving. Bisphosphonates are considered standard antiosteoporotic medication. Other antiresorptive treatment options of osteoporosis include selective oestrogen receptor mo

• Rheumatoid arthritis and osteoporosis.

  Scholarly record2012Caspian journal of internal medicineBehzad Heidari, Mohammad Reza Hassanjani Roushan

  Rheumatoid arthritis is an inflammatory arthritis which changes the biomechanical properties of bones and leads to the alterations in bone components through the increased production of pro-inflammatory cytokines or by hormone mediated mechanisms (1-3). In addition to traditional